I agree that this site is using cookies. You can find further informations here.
X
Fizazi, K.
317  results:
Search for persons X
?
1

Penile cancer: ESMO–EURACAN Clinical Practice Guideline for..:

Muneer, A. ; Bandini, M. ; Compérat, E....
ESMO Open.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Safety, tolerability, and duration of continued darolutamid..:

Fizazi, K. ; Luz, M. ; Ulys, A....
European Urology.  83 (2023)  - p. S1725-S1726 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Tolerability and pharmacokinetic analyses of combination th..:

Tombal, B. ; Smith, M.R. ; Hussain, M....
European Urology.  83 (2023)  - p. S1709-S1710 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Infections occurring following IL6 blockade for the managem..:

Valery, M. ; Saleh, K. ; Ecea, R....
Cancer Chemotherapy and Pharmacology.  92 (2023)  3 - p. 229-233 , 2023
Link: https://doi.org/10.1007/..
 
?
5

177Lu-PSMA-617 dans le cancer de la prostate métastatique r..:

Mahammedi, H. ; Vaishampayan, N. ; Morris, M.J....
Médecine Nucléaire.  47 (2023)  2 - p. 55 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Efficacy and safety of darolutamide (DARO) in combination w..:

Tombal, B. ; Saad, F. ; Fizazi, K....
European Urology.  83 (2023)  - p. S1707-S1708 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Safety and tolerability of long-term treatment with darolut..:

Vjaters, E. ; Fizazi, K. ; James, N.D....
European Urology.  81 (2022)  - p. S786-S787 , 2022
Link: https://doi.org/10.1016/..
 
?
8

PSMAddition : essai de phase 3 comparant le traitement par ..:

Fizazi, K. ; Flippot, R. ; Tagawa, S.T....
Médecine Nucléaire.  46 (2022)  2 - p. 77 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Étude de phase 3 du 177Lu-PSMA-617 dans le traitement des p..:

Fizazi, K. ; Flippot, R. ; Morris, M.J....
Médecine Nucléaire.  46 (2022)  2 - p. 50-51 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Risk of residual teratoma after complete response following..:

Antonelli, L. ; Ardizzone, D. ; Ravi, P....
European Urology Open Science.  45 (2022)  - p. S53 , 2022
Link: https://doi.org/10.1016/..
 
?
11

PSMAfore : essai de phase 3 comparant le 177Lu-PSMA-617 ver..:

Fizazi, K. ; Flippot, R. ; Sartor, O....
Médecine Nucléaire.  46 (2022)  2 - p. 76-77 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Résultats de qualité de vie liée à la santé, douleur et tol..:

Fizazi, K. ; Flippot, R. ; Hermann, K....
Médecine Nucléaire.  46 (2022)  2 - p. 51 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Pan-Asian adapted ESMO Clinical Practice Guidelines for the..:

Kanesvaran, R. ; Castro, E. ; Wong, A....
ESMO Open.  7 (2022)  4 - p. 100518 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Patient (pt) reported pain and health-related quality of li..:

Saad, F. ; Stenzl, A. ; Mehra, N....
European Urology Open Science.  45 (2022)  - p. S172-S174 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Effects of prior local therapy by radical prostatectomy or ..:

Saar, M. ; Fizazi, K. ; Shore, N.D....
European Urology.  81 (2022)  - p. S1423-S1424 , 2022
Link: https://doi.org/10.1016/..
 
1-15